Novel functions of prototype foamy virus Gag glycine-arginine-rich boxes in reverse transcription and particle morphogenesis

Journal of Virology

Volumn 85, Issue 4, 2011, Pages 1452-1463

  Müllers, Erik ^a   Uhlig, Tobias ^a   Stirnnagel, Kristin ^a   Fiebig, Uwe ^b   Zentgraf, Hanswalter ^c   Lindemann, Dirk ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARGININE; DNA; GAG PROTEIN; GLYCINE; RNA; VIRUS VECTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DELETION MUTANT; DNA CONTENT; DNA PACKAGING; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTOTYPE FOAMY VIRUS; REVERSE TRANSCRIPTION; SPUMA VIRUS; VIRUS INFECTIVITY; VIRUS MORPHOGENESIS; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ARGININE; CELL LINE; GENE PRODUCTS, GAG; GLYCINE; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTION; RNA, VIRAL; SPUMAVIRUS; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN SPUMARETROVIRUS;

EID: 78951483245     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01731-10     Document Type: Article

References (47)

1. Bodem, J., M. Zemba, and R. M. Flügel. 1998. Nuclear localization of the functional Bel 1 transactivator but not of the Gag proteins of the feline foamy virus. Virology 251:22-27.
2. Bruss, V. 2007. Hepatitis B virus morphogenesis. World J. Gastroenterol. 13:65-73.
3. Cartellieri, M., et al. 2005. N-terminal Gag domain required for foamy virus particle assembly and export. J. Virol. 79:12464-12476.
4. Cartellieri, M., W. Rudolph, O. Herchenröder, D. Lindemann, and A. Rethwilm. 2005. Determination of the relative amounts of Gag and Pol proteins in foamy virus particles. Retrovirology 2:44.
5. Delelis, O., A. Saib, and P. Sonigo. 2003. Biphasic DNA synthesis in spumaviruses. J. Virol. 77:8141-8146.
6. Didierlaurent, L., L. Houzet, Z. Morichaud, J. L. Darlix, and M. Mougel. 2008. The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation. Nucleic Acids Res. 36:4745-4753.
7. Dorfman, T., A. Bukovsky, A. Ohagen, S. Hoglund, and H. G. Göttlinger. 1994. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:8180-8187.
8. D'Souza, V., and M. F. Summers. 2005. How retroviruses select their genomes. Nat. Rev. Microbiol. 3:643-655.
9. Du Bridge, R. B., et al. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
10. Flügel, R. M. 1991. Spumaviruses: a group of complex retroviruses. J. Acquir. Immune Defic. Syndr. 4:739-750.
11. Gey, G., W. Coffmann, and M. Kubicek. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12:264-265.
12. Hartl, M. J., F. Mayr, A. Rethwilm, and B. M. Wohrl. 2010. Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases. Retrovirology 7:5.
13. Heinkelein, M., et al. 2002. Improved primate foamy virus vectors and packaging constructs. J. Virol. 76:3774-3783.
14. Heinkelein, M., et al. 2002. Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids. J. Virol. 76:10069-10073.
15. Hill, C. L., P. D. Bieniasz, and M. O. McClure. 1999. Properties of human foamy virus relevant to its development as a vector for gene therapy. J. Gen. Virol. 80:2003-2009.
16. Houzet, L., et al. 2008. Nucleocapsid mutations turn HIV-1 into a DNA-containing virus. Nucleic Acids Res. 36:2311-2319.
17. Imrich, H., M. Heinkelein, O. Herchenroder, and A. Rethwilm. 2000. Primate foamy virus Pol proteins are imported into the nucleus. J. Gen. Virol. 81:2941-2947.
18. Jewell, N. A., and L. M. Mansky. 2000. In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly. J. Gen. Virol. 81:1889-1899.
19. Kräusslich, H. G., M. Fäcke, A. M. Heuser, J. Konvalinka, and H. Zentgraf. 1995. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 69:3407-3419.
20. Lecellier, C. H., M. Neves, M. L. Giron, J. Tobaly-Tapiero, and A. Saib. 2002. Further characterization of equine foamy virus reveals unusual features among the foamy viruses. J. Virol. 76:7220-7227.
21. Lee, E. G., and M. L. Linial. 2008. The C terminus of foamy retrovirus Gag contains determinants for encapsidation of Pol protein into virions. J. Virol. 82:10803-10810.
22. Lindemann, D., M. Bock, M. Schweizer, and A. Rethwilm. 1997. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins. J. Virol. 71:4815-4820.
23. Lindemann, D., et al. 2001. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J. Virol. 75:5762-5771.
24. Lindemann, D., and A. Rethwilm. 1998. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J. Virol. 72:4088-4094.
25. Linial, M. L., and S. W. Eastman. 2003. Particle assembly and genome packaging. Curr. Top. Microbiol. Immunol. 277:89-110.
26. Mannigel, I., A. Stange, H. Zentgraf, and D. Lindemann. 2007. Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J. Virol. 81:3317-3326.
27. Moebes, A., et al. 1997. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J. Virol. 71:7305-7311.
28. Moser, B. K., G. R. Stevens, and C. L. Watts. 1989. The two-sample t test versus Satterthwaite's approximate f test. Commun. Stat. Theory Methods 18:3963-3975.
29. Peters, K., T. Wiktorowicz, M. Heinkelein, and A. Rethwilm. 2005. RNA and protein requirements for incorporation of the Pol protein into foamy virus particles. J. Virol. 79:7005-7013.
30. Rasheed, S., W. A. Nelson-Rees, E. M. Toth, P. Arnstein, and M. B. Gardner. 1974. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33:1027-1033.
31. Reicin, A. S., A. Ohagen, L. Yin, S. Hoglund, and S. P. Goff. 1996. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle. J. Virol. 70:8645-8652.
32. Rethwilm, A. 2010. Molecular biology of foamy viruses. Med. Microbiol. Immunol. 199:197-207.
33. Roy, J., et al. 2003. Feline foamy virus genome and replication strategy. J. Virol. 77:11324-11331.
34. Ruxton, G. D. 2006. The unequal variance t-test is an underused alternative to Student's t test and the Mann-Whitney U test. Behav. Ecol. 17:688-690.
35. Saib, A. 2003. Non-primate foamy viruses. Curr. Top. Microbiol. Immunol. 277:197-211.
36. Schliephake, A. W., and A. Rethwilm. 1994. Nuclear localization of foamy virus Gag precursor protein. J. Virol. 68:4946-4954.
37. Stange, A., D. Luftenegger, J. Reh, W. Weissenhorn, and D. Lindemann. 2008. Subviral particle release determinants of prototype foamy virus. J. Virol. 82:9858-9869.
38. Stenbak, C. R., and M. L. Linial. 2004. Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression. J. Virol. 78:9423-9430.
39. Stirnnagel, K., et al. 2010. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 7:45.
40. Thumer, L., A. Rethwilm, E. C. Holmes, and J. Bodem. 2007. The complete nucleotide sequence of a New World simian foamy virus. Virology 369:191-197.
41. Tobaly-Tapiero, J., et al. 2008. Chromatin tethering of incoming foamy virus by the structural Gag protein. Traffic 9:1717-1727.
42. Tobaly-Tapiero, J., et al. 2000. Isolation and characterization of an equine foamy virus. J. Virol. 74:4064-4073.
43. Winkler, I., et al. 1997. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J. Virol. 71:6727-6741.
44. Yu, S. F., et al. 1996. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J. Virol. 70:8255-8262.
45. Yu, S. F., M. D. Sullivan, and M. L. Linial. 1999. Evidence that the human foamy virus genome is DNA. J. Virol. 73:1565-1572.
46. Zamborlini, A., N. Renault, A. Saib, and O. Delelis. 2010. Early reverse transcription is essential for productive foamy virus infection. PLoS One 5:e11023.
47. Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. Virology 247:7-13.